Site 176: Hawaii Pacific Neuroscience — Honolulu, Hawaii

Site 176: Hawaii Pacific Neuroscience is a clinical research site located in Honolulu, Hawaii, United States 96817.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Site 176: Hawaii Pacific Neuroscience has participated in 1 clinical trials.

Therapeutic areas: Myasthenia Gravis, Generalized.

Sponsors: Ra Pharmaceuticals, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Honolulu

Browse all research sites in Hawaii · View every site in Honolulu

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site 176: Hawaii Pacific Neuroscience?

Site 176: Hawaii Pacific Neuroscience has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site 176: Hawaii Pacific Neuroscience conducted?

Site 176: Hawaii Pacific Neuroscience has 1 clinical trials on record. Their work covers Myasthenia Gravis, Generalized.

Is Site 176: Hawaii Pacific Neuroscience accredited by Crixeo Clinical Trials?

Site 176: Hawaii Pacific Neuroscience has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site 176: Hawaii Pacific Neuroscience?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.